FORMULATIONS OF 3-((3-(4-(2-(ISOBUTYLSULFONYL)PHENOXY)-3-(TRIFLUOROMETHYL)PHENYL)-1,2,4-OXADIAZOL-5-YL)METHYL)-5,5-DIMETHYL-1-(2-MORPHOLINOETHYL)IMIDAZOLIDINE-2,4-DIONE

Formulations of 3-((3-(4-(2-(isobutylsulfonyl)phenoxy)-3-(trifluoromethyl)phenyl)-1,2,4-oxadiazol-5-yl)methyl)-5,5-dimethyl-1-(2-morpholinoethyl)imidazolidine-2,4-dione and pharmaceutically acceptable salts thereof, processes for their production, and uses thereof, including in the treatment of ocul...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Hauptverfasser:	SMITH, Jeffrey, SHAW, Duncan, HARDY, Declan, LAKSHMAN, Jay Parthiban, LOREN, Jon Christopher, RAYABANDLA, Sunil Kumar Mandala, RIDRUEJO, Nuria Jimenez, FAN, Yi, MOLTENI, Valentina, HUANG, Zhihong, TOWLER, Christopher Stephen
Format:	Patent
Sprache:	eng
Schlagworte:	HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online-Zugang:	Volltext bestellen
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

container_end_page
container_issue
container_start_page
container_title
container_volume
creator	SMITH, Jeffrey SHAW, Duncan HARDY, Declan LAKSHMAN, Jay Parthiban LOREN, Jon Christopher RAYABANDLA, Sunil Kumar Mandala RIDRUEJO, Nuria Jimenez FAN, Yi MOLTENI, Valentina HUANG, Zhihong TOWLER, Christopher Stephen
description	Formulations of 3-((3-(4-(2-(isobutylsulfonyl)phenoxy)-3-(trifluoromethyl)phenyl)-1,2,4-oxadiazol-5-yl)methyl)-5,5-dimethyl-1-(2-morpholinoethyl)imidazolidine-2,4-dione and pharmaceutically acceptable salts thereof, processes for their production, and uses thereof, including in the treatment of ocular diseases and disorders such as dry eye disease and Meibomian gland dysfunction (MGD).
format	Patent
fullrecord	<record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_US2024238305A1</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>US2024238305A1</sourcerecordid><originalsourceid>FETCH-epo_espacenet_US2024238305A13</originalsourceid><addsrcrecordid>eNqNjsEKgkAQhr10iOodgi4GDuiq0NXaXRxYd0R3IbtExHaKEuyhesxW9AE6DD8z_zf_zDL4SmoqqwqDpNstyW0KYegrg5BBiC0drelUa5Uk3al9XQpN524PHjENSmWpoUqYcva8QBKxKAM6FxyLCynIwU9nBvIoB45TB8l4pKKmLkmhpgnBCvm4hxy1gDGK-9_EOlg8bs_BbWZdBTspzKkE17-vbuhvd_dyn6ttWcwylh7SOC-S9D_qB8FDRqM</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>FORMULATIONS OF 3-((3-(4-(2-(ISOBUTYLSULFONYL)PHENOXY)-3-(TRIFLUOROMETHYL)PHENYL)-1,2,4-OXADIAZOL-5-YL)METHYL)-5,5-DIMETHYL-1-(2-MORPHOLINOETHYL)IMIDAZOLIDINE-2,4-DIONE</title><source>esp@cenet</source><creator>SMITH, Jeffrey ; SHAW, Duncan ; HARDY, Declan ; LAKSHMAN, Jay Parthiban ; LOREN, Jon Christopher ; RAYABANDLA, Sunil Kumar Mandala ; RIDRUEJO, Nuria Jimenez ; FAN, Yi ; MOLTENI, Valentina ; HUANG, Zhihong ; TOWLER, Christopher Stephen</creator><creatorcontrib>SMITH, Jeffrey ; SHAW, Duncan ; HARDY, Declan ; LAKSHMAN, Jay Parthiban ; LOREN, Jon Christopher ; RAYABANDLA, Sunil Kumar Mandala ; RIDRUEJO, Nuria Jimenez ; FAN, Yi ; MOLTENI, Valentina ; HUANG, Zhihong ; TOWLER, Christopher Stephen</creatorcontrib><description>Formulations of 3-((3-(4-(2-(isobutylsulfonyl)phenoxy)-3-(trifluoromethyl)phenyl)-1,2,4-oxadiazol-5-yl)methyl)-5,5-dimethyl-1-(2-morpholinoethyl)imidazolidine-2,4-dione and pharmaceutically acceptable salts thereof, processes for their production, and uses thereof, including in the treatment of ocular diseases and disorders such as dry eye disease and Meibomian gland dysfunction (MGD).</description><language>eng</language><subject>HUMAN NECESSITIES ; HYGIENE ; MEDICAL OR VETERINARY SCIENCE ; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES ; SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><creationdate>2024</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20240718&DB=EPODOC&CC=US&NR=2024238305A1$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,777,882,25545,76296</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20240718&DB=EPODOC&CC=US&NR=2024238305A1$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>SMITH, Jeffrey</creatorcontrib><creatorcontrib>SHAW, Duncan</creatorcontrib><creatorcontrib>HARDY, Declan</creatorcontrib><creatorcontrib>LAKSHMAN, Jay Parthiban</creatorcontrib><creatorcontrib>LOREN, Jon Christopher</creatorcontrib><creatorcontrib>RAYABANDLA, Sunil Kumar Mandala</creatorcontrib><creatorcontrib>RIDRUEJO, Nuria Jimenez</creatorcontrib><creatorcontrib>FAN, Yi</creatorcontrib><creatorcontrib>MOLTENI, Valentina</creatorcontrib><creatorcontrib>HUANG, Zhihong</creatorcontrib><creatorcontrib>TOWLER, Christopher Stephen</creatorcontrib><title>FORMULATIONS OF 3-((3-(4-(2-(ISOBUTYLSULFONYL)PHENOXY)-3-(TRIFLUOROMETHYL)PHENYL)-1,2,4-OXADIAZOL-5-YL)METHYL)-5,5-DIMETHYL-1-(2-MORPHOLINOETHYL)IMIDAZOLIDINE-2,4-DIONE</title><description>Formulations of 3-((3-(4-(2-(isobutylsulfonyl)phenoxy)-3-(trifluoromethyl)phenyl)-1,2,4-oxadiazol-5-yl)methyl)-5,5-dimethyl-1-(2-morpholinoethyl)imidazolidine-2,4-dione and pharmaceutically acceptable salts thereof, processes for their production, and uses thereof, including in the treatment of ocular diseases and disorders such as dry eye disease and Meibomian gland dysfunction (MGD).</description><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><subject>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2024</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNqNjsEKgkAQhr10iOodgi4GDuiq0NXaXRxYd0R3IbtExHaKEuyhesxW9AE6DD8z_zf_zDL4SmoqqwqDpNstyW0KYegrg5BBiC0drelUa5Uk3al9XQpN524PHjENSmWpoUqYcva8QBKxKAM6FxyLCynIwU9nBvIoB45TB8l4pKKmLkmhpgnBCvm4hxy1gDGK-9_EOlg8bs_BbWZdBTspzKkE17-vbuhvd_dyn6ttWcwylh7SOC-S9D_qB8FDRqM</recordid><startdate>20240718</startdate><enddate>20240718</enddate><creator>SMITH, Jeffrey</creator><creator>SHAW, Duncan</creator><creator>HARDY, Declan</creator><creator>LAKSHMAN, Jay Parthiban</creator><creator>LOREN, Jon Christopher</creator><creator>RAYABANDLA, Sunil Kumar Mandala</creator><creator>RIDRUEJO, Nuria Jimenez</creator><creator>FAN, Yi</creator><creator>MOLTENI, Valentina</creator><creator>HUANG, Zhihong</creator><creator>TOWLER, Christopher Stephen</creator><scope>EVB</scope></search><sort><creationdate>20240718</creationdate><title>FORMULATIONS OF 3-((3-(4-(2-(ISOBUTYLSULFONYL)PHENOXY)-3-(TRIFLUOROMETHYL)PHENYL)-1,2,4-OXADIAZOL-5-YL)METHYL)-5,5-DIMETHYL-1-(2-MORPHOLINOETHYL)IMIDAZOLIDINE-2,4-DIONE</title><author>SMITH, Jeffrey ; SHAW, Duncan ; HARDY, Declan ; LAKSHMAN, Jay Parthiban ; LOREN, Jon Christopher ; RAYABANDLA, Sunil Kumar Mandala ; RIDRUEJO, Nuria Jimenez ; FAN, Yi ; MOLTENI, Valentina ; HUANG, Zhihong ; TOWLER, Christopher Stephen</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_US2024238305A13</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng</language><creationdate>2024</creationdate><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</topic><topic>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</topic><toplevel>online_resources</toplevel><creatorcontrib>SMITH, Jeffrey</creatorcontrib><creatorcontrib>SHAW, Duncan</creatorcontrib><creatorcontrib>HARDY, Declan</creatorcontrib><creatorcontrib>LAKSHMAN, Jay Parthiban</creatorcontrib><creatorcontrib>LOREN, Jon Christopher</creatorcontrib><creatorcontrib>RAYABANDLA, Sunil Kumar Mandala</creatorcontrib><creatorcontrib>RIDRUEJO, Nuria Jimenez</creatorcontrib><creatorcontrib>FAN, Yi</creatorcontrib><creatorcontrib>MOLTENI, Valentina</creatorcontrib><creatorcontrib>HUANG, Zhihong</creatorcontrib><creatorcontrib>TOWLER, Christopher Stephen</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>SMITH, Jeffrey</au><au>SHAW, Duncan</au><au>HARDY, Declan</au><au>LAKSHMAN, Jay Parthiban</au><au>LOREN, Jon Christopher</au><au>RAYABANDLA, Sunil Kumar Mandala</au><au>RIDRUEJO, Nuria Jimenez</au><au>FAN, Yi</au><au>MOLTENI, Valentina</au><au>HUANG, Zhihong</au><au>TOWLER, Christopher Stephen</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>FORMULATIONS OF 3-((3-(4-(2-(ISOBUTYLSULFONYL)PHENOXY)-3-(TRIFLUOROMETHYL)PHENYL)-1,2,4-OXADIAZOL-5-YL)METHYL)-5,5-DIMETHYL-1-(2-MORPHOLINOETHYL)IMIDAZOLIDINE-2,4-DIONE</title><date>2024-07-18</date><risdate>2024</risdate><abstract>Formulations of 3-((3-(4-(2-(isobutylsulfonyl)phenoxy)-3-(trifluoromethyl)phenyl)-1,2,4-oxadiazol-5-yl)methyl)-5,5-dimethyl-1-(2-morpholinoethyl)imidazolidine-2,4-dione and pharmaceutically acceptable salts thereof, processes for their production, and uses thereof, including in the treatment of ocular diseases and disorders such as dry eye disease and Meibomian gland dysfunction (MGD).</abstract><oa>free_for_read</oa></addata></record>
fulltext	fulltext_linktorsrc
identifier
ispartof
issn
language	eng
recordid	cdi_epo_espacenet_US2024238305A1
source	esp@cenet
subjects	HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
title	FORMULATIONS OF 3-((3-(4-(2-(ISOBUTYLSULFONYL)PHENOXY)-3-(TRIFLUOROMETHYL)PHENYL)-1,2,4-OXADIAZOL-5-YL)METHYL)-5,5-DIMETHYL-1-(2-MORPHOLINOETHYL)IMIDAZOLIDINE-2,4-DIONE
url	https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-20T23%3A13%3A04IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=SMITH,%20Jeffrey&rft.date=2024-07-18&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3EUS2024238305A1%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true